| 英文别名 |
N-[2-oxo-2-(1,2,3,4-tetrahydronaphthalen-1-ylamino)ethyl]biphenyl-4-carboxamide;TAO Kinase inhibitor 1;CP 43;N-(2-Oxo-2-((1,2,3,4-tetrahydronaphthalen-1-yl)amino)ethyl)-[1,1'-biphenyl]-4-carboxamide;Compound 43 TAO Kinase inhibitor;A928574;N-[2-oxo-2-(1,2,3,4-tetrahydronaphthalen-1-ylamino)ethyl]-4-phenylbenzamide;N-[2-Oxo-2-[(1,2,3,4-tetrahydro-1-naphthalenyl)amino]ethyl][1,1′-biphenyl]-4-carboxamide (ACI);n-[2-oxo-2-(1,2,3,4-tetrahydronaphthalen-1-ylamino)ethyl]biphenyl-4-carboxamide;n-[2-oxo-2-(1,2,3,4-tetrahydronaphthalen-1-ylamino)ethyl]biphenyl-4-carboxamide;E85724;E85724;GS-9008;GS-9008;DB-352489;DB-352489;TAO Kinase inhibitor 1?;TAO Kinase inhibitor 1?;GLXC-15361;GLXC-15361;AKOS037653308;AKOS037653308;HY-112136;HY-112136;EX-A3498;EX-A3498;2-{[1,1'-biphenyl]-4-ylformamido}-N-(1,2,3,4-tetrahydronaphthalen-1-yl)acetamide;2-{[1,1'-biphenyl]-4-ylformamido}-N-(1,2,3,4-tetrahydronaphthalen-1-yl)acetamide;CP43;CP43;SCHEMBL5652046;SCHEMBL5652046;CP-43;CP-43;850467-66-2;850467-66-2;CHEMBL3717933;CHEMBL3717933;CS-0043451;CS-0043451 |
微信公众号
客服
